Melucci

Melucci v. Corcept Therapeutics Incorporated

Good Law
United States District Court, Northern District of CaliforniaAugust 24, 20213:19-cv-01372California18,202 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN JOSE DIVISION

FERRARO FAMILY FOUNDATION, INC. Case No. 19-CV-01372-LHK and JAMES L. FERRARO, on behalf of themselves and all others similarly situated,

ORDER GRANTING IN PART AND

Plaintiffs, DENYING IN PART DEFENDANTS’

MOTION TO DISMISS PLAINTIFFS’

v. THIRD AMENDED COMPLANT

CORCEPT THERAPEUTICS

INCORPORATED, JOSEPH K.

BELANOFF, CHARLES ROBB, and SEAN

MADUCK,

18 Defendants. 19 This case is a putative securities class action against Corcept Therapeutics Incorporated (“Corcept”); its Chief Executive Officer, Joseph K. Belanoff; its Chief Financial Officer, Charles Robb; and its Vice President of Commercial Sean Maduck (collectively, “Defendants”). Lead Plaintiff Ferraro Family Foundation, Inc. and James L. Ferraro (“Plaintiffs”) bring this suit on behalf of “all other persons similarly situated who purchased or otherwise acquired Corcept securities between August 2, 2017 and January 31, 2019, inclusive (the ‘Class Period’).” Third…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.